Watch for Ibsrela, a New Rx for Irritable Bowel Syndrome

June 2022

New Rx Ibsrela (tenapanor) will soon hit shelves for irritable bowel syndrome with constipation (IBS-C) in adults.

It's touted to work differently than other meds for IBS-C...such as Amitiza (lubiprostone), Linzess (linaclotide), or Trulance (plecanatide).

But ultimately, they all increase fluid in the gut to relieve constipation...and there's no proof Ibsrela is more effective.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Practice Work as a Team to Navigate Staffing Shortages
Bites & Stings Sort Through the Swarm of Insect Repellents
Insomnia Think of Quviviq as Similar to Belsomra or Dayvigo for Insomnia
Travel Medicine Listen for Questions About Preventing Blood Clots During Travel
Practice Optimize Care for Patients With Disabilities
Specialty Meds Understand Unique Considerations With Specialty Meds
Cancer Help Overcome Barriers With Opioid Rxs for Cancer Pain
Med Safety Improve Safety With PDE5 Inhibitors
IBS Watch for Ibsrela, a New Rx for Irritable Bowel Syndrome